ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2192

Vitamin D Receptor Polymorphisms In A Cohort Of Italian Patients With Juvenile Idiopathic Arthritis

Fernanda Falcini1, Francesca Marini2, Donato Rigante3, Federico Bertini4, Gemma Lepri5, Stefano Stagi6, Marco Matucci Cerinic7 and Maria Luisa Brandi8, 1Department of Biomedicine, Division of Rheumatology AOUC, Excellence Centre for Research, Florence, Italy, 2Surgery and Translational Medicine, University of Florence, Firenze, Italy, 3Pediatrics, Università Cattolica Sacro Cuore, Rome, Italy, 4Department of Internal Medicine, Rheumatology Section, University of Florence, Florence, Italy, 5Department of Internal Medicine, Section of Rheumatology, Transition Clinic, University of Florence, Florence, Italy, 6Pediatric Endocrinology Unit, Anna Meyer Children’s Hospital, University of Florence, Firenze, Italy, 7Department of Biomedicine, Division of Rheumatology, University of Florence, Florence, Italy, 8Surgery and Translational Medicine, University of Florence, Florence, Italy

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: juvenile idiopathic arthritis (JIA)

  • Tweet
  • Email
  • Print
Session Information

Title: Pediatric Rheumatology - Pathogenesis and Genetics

Session Type: Abstract Submissions (ACR)

Background/Purpose:

A role for vitamin D has been hypothesized in generating disease activity for patients with juvenile idiopathic arthritis (JIA): specific polymorphisms of vitamin D receptor (VDR) gene have recently been associated with different biologic response to vitamin D itself.

To evaluate VDR polymorphisms in patients with JIA in comparison with unrelated healthy controls.

Methods:

We recruited 81 Italian children, adolescents and young adults with JIA (mean age 20.21 + 7.11 SD, 67 female and 14 males, female/male ratio 4.79). After informed consent, during routine laboratory tests their genomic DNA was extracted from peripheral blood leukocytes, to analyze VDR polymorphisms by PCR-based sequencing (CDX2 in the promoter region) and PCR-based enzymatic digestions (FokI in exon 2, BsmI and ApaI in intron 8, and TaqI in exon 9). An Italian population of 2221 unrelated individuals without JIA was used as healthy controls.

 

Results:

The distribution of FokI, BsmI, ApaI, and TaqI polymorphisms did not show significant differences between children with JIA and controls. Regarding the CDX2 polymorphism, we observed a statistical difference in the distribution of GG and GA genotypes, with the GG genotype more frequent in JIA subjects (Yates-corrected chi-square 6.64; Odds ratio=1.87; p=0.01) and the GA genotype in healthy controls (Yates-corrected chi-square 4.47; Odds ratio=0.58; p=0.035). Data about AA genotype were not significant due to their very low number (five) within the JIA population. G allele resulted to be more frequent in JIA subjects (Yates-corrected chi-square 5,64; Odds ratio=1.61; p=0.017).

Conclusion:

Pathogenetic mechanisms influencing the predisposition to JIA are poorly elucidated. Our analysis of CDX2 polymorphisms (located in the promoter region of the VDR gene) has revealed that both GG genotype and G allele are more represented in patients with JIA. We can speculate that the G allele decreases VDR transcriptional activity with respect to the A allele, as well as the presence of GG genotype could explain a reduction of VDR activity, with subsequent decreased response to vitamin D and potential immunity deregulation leading to JIA.

 

 

 

 

 

 

 


Disclosure:

F. Falcini,
None;

F. Marini,
None;

D. Rigante,
None;

F. Bertini,
None;

G. Lepri,
None;

S. Stagi,
None;

M. Matucci Cerinic,
None;

M. L. Brandi,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/vitamin-d-receptor-polymorphisms-in-a-cohort-of-italian-patients-with-juvenile-idiopathic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology